- Home
- ATLO vs INBX Comparison
ATLO vs INBX Comparison
Compare ATLO & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATLO
- INBX
- Stock Information
- Founded
- ATLO 1903
- INBX 2010
- Country
- ATLO United States
- INBX United States
- Employees
- ATLO N/A
- INBX N/A
- Industry
- ATLO Major Banks
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- ATLO Finance
- INBX Health Care
- Exchange
- ATLO Nasdaq
- INBX Nasdaq
- Market Cap
- ATLO 144.8M
- INBX 218.9M
- IPO Year
- ATLO N/A
- INBX 2020
- Fundamental
- Price
- ATLO $16.98
- INBX $12.74
- Analyst Decision
- ATLO
- INBX Hold
- Analyst Count
- ATLO 0
- INBX 1
- Target Price
- ATLO N/A
- INBX N/A
- AVG Volume (30 Days)
- ATLO 29.1K
- INBX 74.4K
- Earning Date
- ATLO 01-21-2025
- INBX 11-14-2024
- Dividend Yield
- ATLO 6.00%
- INBX N/A
- EPS Growth
- ATLO N/A
- INBX N/A
- EPS
- ATLO 0.98
- INBX 119.38
- Revenue
- ATLO $51,071,000.00
- INBX $1,568,000.00
- Revenue This Year
- ATLO N/A
- INBX N/A
- Revenue Next Year
- ATLO N/A
- INBX N/A
- P/E Ratio
- ATLO $17.06
- INBX $0.11
- Revenue Growth
- ATLO N/A
- INBX 19.24
- 52 Week Low
- ATLO $15.69
- INBX $10.80
- 52 Week High
- ATLO $22.41
- INBX $18.95
- Technical
- Relative Strength Index (RSI)
- ATLO 55.06
- INBX 32.23
- Support Level
- ATLO $16.04
- INBX $13.57
- Resistance Level
- ATLO $16.62
- INBX $16.83
- Average True Range (ATR)
- ATLO 0.40
- INBX 0.94
- MACD
- ATLO 0.09
- INBX -0.21
- Stochastic Oscillator
- ATLO 90.44
- INBX 1.68
About ATLO Ames National Corporation
Ames National Corporation is a United States-based bank holding company. Through its subsidiaries, it provides checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit of payroll and social security checks, and automated/video teller machine access. Its loan portfolio comprises commercial, residential & agricultural real estate loans; agricultural & business operating loans & lines of credit; equipment loans; vehicle loans; personal loans; and mortgage loans. Its operations are conducted in central, north central, and south-central Iowa.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.